How it works (for clinicians)
High‑level overview suitable for public website; technical details available under NDA.
Data privacy & governance: patient‑level data are de‑identified; model development follows applicable data protection standards in participating jurisdictions.
What we do - (for everyone)
Infertility affects millions of families. IVF works—but outcomes depend heavily on selecting the right embryo for transfer. Today, selection relies on morphology, time‑lapse imaging, and invasive genetic testing that adds cost and complexity.
Our approach is different: we analyze signals available from a standard IVF workflow to rank embryos by their likelihood of successful implantation—without biopsies or changes to lab routines. The goal is better selection with the same embryos you already have.
Why it matters – Fewer transfers per live birth – Lower overall treatment cost and burden – A path to faster time‑to‑pregnancy – Non‑invasive and clinic‑friendly
We are here for you and ready to advise you
Leave us your contact information
Clinical program & timeline
Clinics interested in pilot participation can contact us below.
Phase
Ongoing Phase 1 clinical development focused on feasibility and prospective validation of the ranking methodology in real‑world IVF clinic settings.
Objectives
Assess concordance between predicted ranking and actual implantation outcomes Evaluate usability within embryology workflow Confirm non‑invasiveness and safety
Next steps
expand multi‑center prospective studies and prepare regulatory path as required per market
For IVF clinics
Pilot with us – Quick onboarding; minimal training – Works alongside your current selection methods – Dashboard with ranked embryo list and audit trail – Dedicated support and study toolkit
Get started: Request a technical briefing and pilot pack.
For patients
We partner with accredited IVF clinics and do not offer treatments directly. Please consult your clinic and share our public explainer.
Evidence & research
We are building a growing body of evidence, including retrospective analyses and prospective clinical data collection. A public summary of study protocols and aggregated performance will be published as milestones are reached. For detailed results, please reach out for our Clinical Evidence Brief (under NDA).
Intellectual property
Fetus IVF maintains a portfolio of patent filings covering non‑invasive embryo assessment workflows and predictive modeling. Details available on request.
About us
Fetus IVF is a biotechnology company focused on improving IVF outcomes through non‑invasive embryo selection. Our team spans embryology, reproductive medicine, biostatistics, and machine learning.
Leadership
Robert Artur Pierug, Robert Flocius
Advisors
Roman Oros
